Comparison of Chemotherapeutic Treatment Outcomes of Advanced Extrapulmonary Neuroendocrine Carcinomas and Advanced Small-Cell Lung Carcinoma

Publisher： Karger

E-ISSN： 1423-0194|96|4|324-332

ISSN： 0028-3835

Source： Neuroendocrinology, Vol.96, Iss.4, 2012-08, pp. : 324-332

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Oxaliplatin-Based Chemotherapy in Advanced Neuroendocrine Tumors: Clinical Outcomes and Preliminary Correlation with Biological Factors

By  

Neuroendocrinology, Vol. 103, Iss. 6, 2016-01 ,pp. : 806-814

Karger

Access to resources Recommend Favorite

Treatment with the Radiolabelled Somatostatin Analog 177Lu-DOTATATE for Advanced Pancreatic Neuroendocrine Tumors

By  

Neuroendocrinology, Vol. 97, Iss. 4, 2013-05 ,pp. : 347-354

Karger

Access to resources Recommend Favorite

Temozolomide in Advanced Neuroendocrine Neoplasms: Pharmacological and Clinical Aspects

By  

Neuroendocrinology, Vol. 101, Iss. 4, 2015-04 ,pp. : 274-288

Karger

Access to resources Recommend Favorite

ENETS Consensus Guidelines for Neuroendocrine Neoplasms of the Appendix (Excluding Goblet Cell Carcinomas)

By  

Neuroendocrinology, Vol. 103, Iss. 2, 2016-01 ,pp. : 144-152

Karger

Access to resources Recommend Favorite

Risk Factors for Disease Progression in Advanced Jejunoileal Neuroendocrine Tumors

By  

Neuroendocrinology, Vol. 96, Iss. 1, 2011-12 ,pp. : 32-40

Karger

Access to resources Recommend Favorite